Compugen Ltd.

NASDAQ:CGEN

Biotechnology

Healthcare
$1.96 +0.50%

+$0.01 today

Market cap
$185.66M
Beta
2.74
P/E (TTM)
5.4
EPS (TTM)
$0.37
52W Low $1.30High $3.24

Volume 0.15M

Average 0.48M

Income Statement

Follow revenue through to earnings.

Revenue

$72.76M

FY 2025 · Annual

+161.1% YoY

Operating Income

$31.33M

FY 2025 · Annual

Net Income

$35.34M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6M7.5M33.46M27.86M72.76M
Cost of Revenue680K975K2M7.93M9.25M
Gross Profit5.32M6.53M31.46M19.93M63.51M
Gross Margin88.7%87.0%94.0%71.5%87.3%
Research & Development28.69M30.65M34.47M24.81M22.76M
Selling, General & Admin11.7M11.25M9.98M10.02M9.43M
Operating Expenses40.39M41.9M44.45M34.83M32.19M
Depreciation & Amortization461K482K476K486K475K
EBITDA(33.72M)(33.13M)(9.28M)(9.19M)35.87M
EBITDA Margin-562.0%-441.7%-27.7%-33.0%49.3%
Operating Income(35.07M)(35.37M)(12.99M)(14.89M)31.33M
Operating Margin-584.6%-471.7%-38.8%-53.4%43.1%
Interest Income894K1.44M3.24M5.24M4.41M
Interest Expense25K27K31K34K0
Other Income / Expenses871K1.74M3.21M5.18M4.07M
Income Before Tax(34.2M)(33.64M)(9.78M)(9.71M)35.4M
Pre-Tax Margin-570.0%-448.5%-29.2%-34.8%48.6%
Income Tax Expense058K8.97M4.52M54K
Net Income(34.2M)(33.69M)(18.75M)(14.23M)35.34M
Net Margin-570.0%-449.3%-56.1%-51.1%48.6%
EPS (Basic)(0.41)(0.39)(0.21)(0.16)0.38
EPS (Diluted)(0.41)(0.39)(0.21)(0.16)0.38
Weighted Avg Shares84.2M86.56M87.63M89.53M93.43M
Weighted Avg Shares (Diluted)84.2M86.56M87.63M89.53M93.82M

CGEN Earnings Waterfall · TTM

NASDAQ:CGEN · Revenue to Net Income

Key Ratios

EPS$0.37
Gross Margin22.8%
Net Margin-305.3%
P/E Ratio-4.1
P/S Ratio75.0

Analysis

$72.7M of revenue converted into $34.9M of net income for the selected period. Gross margin is 22.8% and net margin is -305.3%, showing how much revenue survives after costs and taxes. EPS is $0.37, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 9, 2026
6-K6-K filingSep 10, 2026
6-K6-K filingAug 3, 2026
6-K6-K filingAug 3, 2026
4Statement of changes in beneficial ownershipJul 30, 2026

How much revenue does CGEN generate?

Compugen Ltd. (CGEN) reported $72.76M of revenue in fiscal 2025.

Is CGEN profitable?

Compugen Ltd. (CGEN) reported $35.34M of net income, with a net margin of 48.6%.